OBJECTIVES: Depressive symptoms are common in schizophrenia spectrum disorders and may influence how patients engage with treatment. This study examined whether depressive symptom severity affects motivation for treatment or satisfaction with inpatient care in patients with schizophrenia spectrum disorders. METHODS: = 24). Symptom severity was assessed at admission and discharge using the Hamilton depression rating scale and the positive and negative syndrome scale. Attitudes towards treatment (FPTM) were assessed at admission, and treatment satisfaction (ZUF-8) at discharge. RESULTS: Treatment satisfaction was generally high and did not differ between depressive symptom groups. Greater depressive symptom severity was associated with higher mental distress. Higher initiative to engage in psychotherapy correlated positively with treatment satisfaction. Older age was also associated with greater satisfaction. CONCLUSIONS: Treatment satisfaction in schizophrenia spectrum disorders appeared largely independent of depressive symptom severity. In contrast, patients' motivation to engage in treatment was closely related to satisfaction, suggesting that motivation may play a more decisive role in shaping treatment experience than symptom severity alone. Early support of treatment motivation and further integrative research are warranted.
Rothenberg et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: